Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

ClinicalTrials.gov ID: NCT01170221

Public ClinicalTrials.gov record NCT01170221. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 7:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of 6-Day Oral TR-701 Free Acid and 10-Day Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, double dummy, multicenter Phase 3 study of oral TR-701 FA 200 mg once daily for 6 days versus oral Zyvox® (linezolid) 600 mg every 12 hours for 10 days for the treatment of ABSSSI in adults. Approximately 75 to 100 sites globally will participate in this study. Patients with an ABSSSI caused by suspected or documented gram positive pathogen(s) at baseline will be randomized 1:1 to study treatment

Study identification

NCT ID
NCT01170221
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
667 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 15, 2010 (Actual)
Primary completion
Sep 30, 2011 (Actual)
Completion
Sep 30, 2011 (Actual)
Last update posted
Aug 29, 2018

2010 – 2011

United States locations

U.S. sites
30
U.S. states
12
U.S. cities
25
Facility City State ZIP Site status
Trius investigator site 109 Dothan Alabama 36301 —
Trius Investigator site 130 Anaheim California 92801 —
Trius investigator site 118 Anaheim California 92804 —
Trius investigator site 129 Buena Park California 90620 —
Trius Investigator Site 103 Chula Vista California 91911 —
Trius Investigator Site 105 La Mesa California 91942 —
Trius investigator site 126 Laguna Beach California 92651 —
Trius investigator site 125 Norwalk California 90650 —
Trius Investigator Site 104 Oceanside California 92056 —
Trius investigator site 113 Oxnard California 93030 —
Trius investigator site 123 Pasadena California 91105 —
Trius Investigator Site 106 Rolling Hills Estates California 90274 —
Trius investigator site 111 Torrance California 90501 —
Trius investigator site 132 Torrance California 90502 —
Trius investigator site 127 Fort Lauderdale Florida 33308 —
Trius investigator site 135 Hialeah Florida 33012 —
Trius investigator site 101 Columbus Georgia 31904 —
Trius Investigator Site 102 Savannah Georgia 31406 —
Trius Investigator site 116 Chicago Illinois 60637 —
Trius Investigator Site 108 Springfield Illinois 62701 —
Trius investigator site 112 Evansville Indiana 47714 —
Trius Investigator Site 107 Detroit Michigan 48202 —
Trius investigator site 133 Butte Montana 59701 —
Trius investigator site 128 Las Vegas Nevada 89109 —
Trius investigator site 115 Somers Point New Jersey 08244 —
Trius investigator site 114 Toledo Ohio 43608 —
Trius investigator site 122 Houston Texas 77002 —
Trius investigator site 120 Houston Texas 77005 —
Trius investigator site 131 Houston Texas 77081 —
Trius Investigator site 121 Houston Texas 77093 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01170221, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 29, 2018 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01170221 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →